Gynecologic Pathology: Masters of Pathology Series
- Earn up to 14.25 CME credits | ABPath
Media Formats Choose Video Option:Online – $895Online + USB – $1,045Online + USB + Printed Syllabus – $1,270
Anticipated Release Date: April 30, 2026
Starting at$895.00Current Stock:
Quick Facts
a CMEinfo video production
Accredited by:Oakstone Publishing
Course Director:
Brooke E. Howitt, MD
Associate Professor and Irene Adler Endowed Scholar
Department of Pathology
Stanford University School of Medicine
Associate Director, Gynecologic Pathology Service
Associate Director, Gynecologic Pathology Fellowship Program
Stanford, CA
Credits:Earn a maximum of 14.25 AMA PRA Category 1 Credits™
Overview
Coming Soon: Pre-Order Today!
CME Guide to Gynecologic Pathology Advances
In this online CME program, you’ll encounter the latest discoveries and diagnostic challenges in gynecologic pathology, focusing on biopsies, resections, and gestational trophoblastic neoplasia. You’ll examine commonly encountered specimens such as endometrial and cervical biopsies, as well as the complex mesenchymal lesions that often pose diagnostic difficulties.
Organized by anatomic location and neoplasia subtypes, the Gynecologic Pathology course — part of our Masters of Pathology Series — will help you build a structured and practical approach to interpreting a wide range of gynecologic specimens. It’s continuing medical education that:
- Ensures you’re current with novel emerging diagnostic classification schemes and the newly developed endometrial staging system
- Previews the upcoming 6th edition of the WHO blue book, offering insight into key updates
- Demonstrates how to integrate a wide array of immunohistochemical stains and molecular assays alongside morphologic features in surgical pathology
Topics / Speakers
Classification of Vulvar Squamous Lesions – Non-Invasive – Jaclyn Watkins, MD, MS
Classification and Staging of Vulvar Squamous Cell Carcinoma – Jaclyn Watkins, MD, MS
Vulvovaginal Mesenchymal Lesions – Tumors – Marisa R. Nucci, MD
Squamous Dysplasia of the Lower Anogenital Tract – Eric Yang, MD, PhD
Classification of Cervical Glandular Lesions – Non-Invasive – Kay Park, MD
Slide Session – Non-Invasive Glandular Lesions of the Cervix – Kay Park, MD
Classification of Invasive Cervical Adenocarcinoma – Kay Park, MD
Staging of Cervical Carcinomas – Kay Park, MD
Slide Session – HPVA Adenocarcinomas – Kay Park, MD
Slide Session – HPVI Adenocarcinomas – Kay Park, MD
Approach to the Endometrial Biopsy – Jaclyn Watkins, MD, MS
Diagnosis of Atypical Hyperplasia-EIN and Progestin Therapy – Brooke E. Howitt, MD
Endometrial Carcinoma – Molecular Classification – Brooke E. Howitt, MD
Endometrial Carcinoma – Integration of Histotype and Molecular Subtype – Brooke E. Howitt, MD
FIGO 2023 Endometrial Cancer Staging – Joseph Rabban MD MPH
High Risk Endometrial Cancers that Mimic Low Grade Endometrioid Carcinoma – Joseph Rabban, MD, MPH
Smooth Muscle Tumors of the Uterus and Mimics – Brooke E. Howitt, MD
Endometrial Stromal and Non-Smooth Muscle Mesenchymal Neoplasms – Brooke E. Howitt, MD
Adenosarcoma and Mimics – Brooke E. Howitt, MD
Pre-Invasive Lesions of the Fallopian Tube – Brooke E. Howitt, MD
Slide Session – Lesions of the Fallopian Tube – Brooke E. Howitt, MD
Serous Borderline-Low-Grade Serous Carcinomas of the Ovary and Implants – Teri A. Longacre, MD
Approach to Tumor Typing of High Risk Ovarian Cancers – Joseph Rabban, MD, MPH
Sex Cord Stromal Tumors of the Ovary – Part 1 – Jaclyn Watkins, MD, MS
Sex Cord Stromal Tumors of the Ovary – Part 2 – Jaclyn Watkins, MD, MS
Endometriosis and Endometriosis-Associated Cancers – Jaclyn Watkins, MD, MS
First Trimester POCs – What Not to Miss – Jaclyn Watkins, MD, MS
Gestational Trophoblastic Disease – Ann Folkins, MD
Biomarker Interpretation in Gynecologic Tumors – Brooke E. Howitt, MD
Faculty
Course Director
Brooke E. Howitt, MD
Associate Professor and Irene Adler Endowed Scholar
Department of Pathology
Stanford University School of Medicine
Associate Director, Gynecologic Pathology Service
Associate Director, Gynecologic Pathology Fellowship Program
Stanford, CA
Faculty
Ann Folkins, MD
Associate Professor of Pathology
Department of Pathology
Stanford University School of Medicine
Co-Director of Surgical Pathology
Director of Quality for Department of Pathology
Stanford Health Care
Stanford, CA
Teri A. Longacre, MD
Professor of Pathology
Emerita Richard Kempson Endowed Professor of Surgical Pathology
Director, Gastrointestinal Pathology
Director, Gynecologic Pathology
Stanford Medicine and Stanford Cancer Center
Stanford University School of Medicine
Stanford, CA
Marisa R. Nucci, MD
Professor of Pathology
Harvard Medical School
Director, Women’s and Perinatal Pathology
Brigham and Women’s Hospital
Pathologist, Brigham and Women’s Hospital
Boston, MA
Kay Park, MD
Attending Pathologist
Chair, Graduate Medical Education Committee
Program Director, Gynecologic Pathology Fellowship
Department of Pathology and Laboratory Medicine
Memorial Sloan Kettering Cancer Center
New York, NY
Joseph Rabban, MD, MPH
Professor of Pathology
Director, Gynecological Pathology Service
Director, Gynecological Pathology Fellowship
University of California San Francisco
Department of Pathology
San Francisco, CA
Jaclyn Watkins, MD, MS
Associate Professor of Clinical Pathology
Pathology and Laboratory Medicine
UC Davis Medical Center
Davis, CA
Eric Yang, MD, PhD
Clinical Professor
Director, Computational Pathology and Digital Innovation
Director, Cytopathology Fellowship
Stanford University School of Medicine
Stanford, CA
Accreditation
Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
Oakstone Publishing designates this enduring material for a maximum of 14.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Pathology’s (ABPath) Continuing Certification program requirements for Part II (CME) Lifelong Learning.
Date of Original Release: April 30, 2026
Credit Expiration Date:April 29, 2029
Estimated Time to Complete: 14.25 hours
CME credit is awarded upon successful completion of a course evaluation and post-test.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the classification of vulvar squamous neoplasia and current staging approaches for vulvar cancer
- Describe the classification of cervical squamous and glandular neoplasia and current staging approaches for cervical cancer
- Apply the TCGA molecular classification of endometrial carcinoma and explain its implications for FIGO staging
- Recognize preinvasive endometrial lesions and diagnostic considerations in patients receiving progestin therapy
- Determine appropriate ancillary testing strategies for the diagnosis of uterine mesenchymal neoplasms
- Describe morphologic and immunohistochemical features of serous tubal intraepithelial carcinoma and other p53-abnormal lesions of the fallopian tube lesions
- Assess low-grade serous neoplasia and associated peritoneal implants
- Describe key morphologic features and ancillary testing approaches used in the diagnosis of ovarian carcinomas
Target Audience
This educational activity is intended for pathologists, gynecologic oncologists, and pathology trainees (residents, fellows).
SKU: PAV582E0
About Oakstone
About Ebix
Ebix | Oakstone Publishing
1 Ebix Way
Johns Creek, GA 30097
Copyright © 2026 Ebix Inc. Terms of Service | Privacy Policy | Sitemap